PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VTVT vs. IUSV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VTVT and IUSV is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VTVT vs. IUSV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in vTv Therapeutics Inc. (VTVT) and iShares Core S&P U.S. Value ETF (IUSV). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
20.21%
2.91%
VTVT
IUSV

Key characteristics

Sharpe Ratio

VTVT:

0.84

IUSV:

1.30

Sortino Ratio

VTVT:

2.29

IUSV:

1.88

Omega Ratio

VTVT:

1.31

IUSV:

1.23

Calmar Ratio

VTVT:

1.14

IUSV:

1.65

Martin Ratio

VTVT:

2.85

IUSV:

4.69

Ulcer Index

VTVT:

39.10%

IUSV:

2.90%

Daily Std Dev

VTVT:

132.29%

IUSV:

10.44%

Max Drawdown

VTVT:

-98.19%

IUSV:

-60.18%

Current Drawdown

VTVT:

-95.36%

IUSV:

-4.20%

Returns By Period

In the year-to-date period, VTVT achieves a 46.28% return, which is significantly higher than IUSV's 2.89% return.


VTVT

YTD

46.28%

1M

49.85%

6M

20.27%

1Y

131.92%

5Y*

-31.57%

10Y*

N/A

IUSV

YTD

2.89%

1M

0.46%

6M

2.91%

1Y

12.32%

5Y*

11.03%

10Y*

10.06%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VTVT vs. IUSV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VTVT
The Risk-Adjusted Performance Rank of VTVT is 7979
Overall Rank
The Sharpe Ratio Rank of VTVT is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of VTVT is 8585
Sortino Ratio Rank
The Omega Ratio Rank of VTVT is 8484
Omega Ratio Rank
The Calmar Ratio Rank of VTVT is 8282
Calmar Ratio Rank
The Martin Ratio Rank of VTVT is 7272
Martin Ratio Rank

IUSV
The Risk-Adjusted Performance Rank of IUSV is 5454
Overall Rank
The Sharpe Ratio Rank of IUSV is 5454
Sharpe Ratio Rank
The Sortino Ratio Rank of IUSV is 5555
Sortino Ratio Rank
The Omega Ratio Rank of IUSV is 5353
Omega Ratio Rank
The Calmar Ratio Rank of IUSV is 5858
Calmar Ratio Rank
The Martin Ratio Rank of IUSV is 4848
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VTVT vs. IUSV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for vTv Therapeutics Inc. (VTVT) and iShares Core S&P U.S. Value ETF (IUSV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VTVT, currently valued at 0.84, compared to the broader market-2.000.002.000.841.30
The chart of Sortino ratio for VTVT, currently valued at 2.29, compared to the broader market-4.00-2.000.002.004.006.002.291.88
The chart of Omega ratio for VTVT, currently valued at 1.31, compared to the broader market0.501.001.502.001.311.23
The chart of Calmar ratio for VTVT, currently valued at 1.14, compared to the broader market0.002.004.006.001.141.65
The chart of Martin ratio for VTVT, currently valued at 2.85, compared to the broader market-10.000.0010.0020.0030.002.854.69
VTVT
IUSV

The current VTVT Sharpe Ratio is 0.84, which is lower than the IUSV Sharpe Ratio of 1.30. The chart below compares the historical Sharpe Ratios of VTVT and IUSV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.84
1.30
VTVT
IUSV

Dividends

VTVT vs. IUSV - Dividend Comparison

VTVT has not paid dividends to shareholders, while IUSV's dividend yield for the trailing twelve months is around 2.09%.


TTM20242023202220212020201920182017201620152014
VTVT
vTv Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IUSV
iShares Core S&P U.S. Value ETF
2.09%2.15%1.75%2.22%1.87%2.40%2.19%2.66%1.93%2.18%2.54%1.86%

Drawdowns

VTVT vs. IUSV - Drawdown Comparison

The maximum VTVT drawdown since its inception was -98.19%, which is greater than IUSV's maximum drawdown of -60.18%. Use the drawdown chart below to compare losses from any high point for VTVT and IUSV. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-95.36%
-4.20%
VTVT
IUSV

Volatility

VTVT vs. IUSV - Volatility Comparison

vTv Therapeutics Inc. (VTVT) has a higher volatility of 26.46% compared to iShares Core S&P U.S. Value ETF (IUSV) at 2.47%. This indicates that VTVT's price experiences larger fluctuations and is considered to be riskier than IUSV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
26.46%
2.47%
VTVT
IUSV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab